tibolone has been researched along with Uterine Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 19 (65.52) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cancelo Hidalgo, MJ | 1 |
| Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
| Neves-E-Castro, M | 1 |
| Carranza Lira, S | 1 |
| Schindler, AE | 1 |
| Karakus, C; Simsek, T; Trak, B | 1 |
| Göçmen, A; Kara, IH; Karaca, M | 1 |
| De Falco, M; De Rosa, G; Di Lieto, A; Mansueto, G; Pollio, F; Staibano, S | 1 |
| Lethaby, A; Vollenhoven, B | 2 |
| Ciociola, F; De Falco, M; Di Lieto, A; Mansueto, G; Pollio, F; Pontillo, M; Salvatore, G; Staibano, S | 1 |
| Busiello, A; Carbone, IF; D'Armiento, FP; De Falco, M; Di Lieto, A; Mascolo, M; Pollio, F; Salvatore, G; Staibano, S | 1 |
| Fogelman, I; Morris, EP; Robinson, J; Rymer, J | 1 |
| Lethaby, AE; Vollenhoven, BJ | 1 |
| Falbo, A; Oppedisano, R; Orio, F; Palomba, S; Tolino, A; Zullo, F | 1 |
| Davies, AP; Oram, D | 1 |
| Bennink, HJ; Kicovic, P; Lindsay, PC; Shaw, RW | 1 |
| Ginsburg, J; Prelevic, GM | 1 |
| Chryssikopoulos, A; Costomenos, D; Gregoriou, O; Konidaris, S; Papadias, C; Vitoratos, N | 1 |
| Affinito, P; Nappi, C; Palomba, S; Tommaselli, GA | 1 |
| Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V | 1 |
| Affinito, P; Bifulco, G; Di Carlo, C; Nappi, C; Palomba, S | 1 |
| Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G | 1 |
| D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V | 1 |
| Affinito, P; Di Carlo, C; Nappi, C; Palomba, S; Pellicano, M; Zullo, F | 1 |
| Botsis, D; Creatsas, G; Gregoriou, O; Konidaris, S; Makrakis, E; Papadias, C | 1 |
| Ang, WC; Farrell, E; Vollenhoven, B | 1 |
| Mastrantonio, P; Morelli, M; Noia, R; Oliverio, A; Palomba, S; Santagata, M; Sena, T; Zullo, F | 1 |
| Di Carlo, C; Morelli, M; Noia, R; Palomba, S; Pellicano, M; Zullo, F | 1 |
8 review(s) available for tibolone and Uterine Neoplasms
| Article | Year |
|---|---|
[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
Topics: Combined Modality Therapy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Norpregnenes; Progesterone; Progestins; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms | 2008 |
[Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
Topics: Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Uterine Neoplasms | 2008 |
Fibroids (uterine myomatosis, leiomyomas).
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysterectomy, Vaginal; Leiomyoma; Norpregnenes; Progestins; Uterine Neoplasms | 2004 |
Fibroids (uterine myomatosis, leiomyomas).
Topics: Antineoplastic Agents, Hormonal; Diagnosis, Differential; Drug Therapy, Combination; Estrogen Receptor Modulators; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Leiomyoma; Leiomyomatosis; Leuprolide; Norpregnenes; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Uterine Neoplasms | 2005 |
An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Topics: Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estrogen Antagonists; Evidence-Based Medicine; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Premenopause; Progestins; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Neoplasms | 2008 |
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms | 2001 |
18 trial(s) available for tibolone and Uterine Neoplasms
| Article | Year |
|---|---|
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
The effects of add-back therapy with tibolone on myoma uteri.
Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Prospective Studies; Treatment Outcome; Triptorelin Pamoate; Ultrasonography; Uterine Neoplasms | 2002 |
Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
Topics: Antineoplastic Agents, Hormonal; Female; Fibroblast Growth Factor 2; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Leiomyoma; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Norpregnenes; Platelet-Derived Growth Factor; Premenopause; Uterine Neoplasms; Uterus; Vascular Endothelial Growth Factor A | 2005 |
Expression of proliferating cell nuclear antigen and bcl-2 during a pseudomenopausal state induced by presurgical treatment of uterine leiomyomas with gonadotropin-releasing hormone analogues plus tibolone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Leiomyoma; Leuprolide; Norpregnenes; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Uterine Neoplasms | 2005 |
Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
Topics: Adult; Antineoplastic Agents, Hormonal; Bone Density; Connective Tissue Growth Factor; Drug Therapy, Combination; Female; Hemoglobins; Hot Flashes; Humans; Immediate-Early Proteins; Immunohistochemistry; Injections, Subcutaneous; Intercellular Signaling Peptides and Proteins; Iron; Leiomyoma; Leuprolide; Myometrium; Neoadjuvant Therapy; Norpregnenes; Transforming Growth Factor beta; Transforming Growth Factor beta3; Uterine Neoplasms | 2006 |
Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Topics: Adult; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Density; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Middle Aged; Norpregnenes; Patient Compliance; Placebos; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2008 |
Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
Topics: Administration, Oral; Adult; Affect; Antineoplastic Agents, Hormonal; Central Nervous System Agents; Cognition; Delayed-Action Preparations; Female; Humans; Leiomyoma; Leuprolide; Middle Aged; Norpregnenes; Quality of Life; Single-Blind Method; Time Factors; Treatment Outcome; Uterine Neoplasms | 2008 |
The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
Topics: Adult; Anabolic Agents; Bone Density; Double-Blind Method; Drug Interactions; Endometriosis; Female; Humans; Leiomyoma; Luteolytic Agents; Norpregnenes; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms | 1996 |
Effect of tibolone on postmenopausal women with myomas.
Topics: Anabolic Agents; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Ultrasonography; Uterine Neoplasms | 1997 |
A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Bone Density; Climacteric; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Lipids; Muscle, Smooth, Vascular; Norpregnenes; Prospective Studies; Ultrasonography; Uterine Neoplasms | 1998 |
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms | 1998 |
Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles.
Topics: Adult; Antineoplastic Agents, Hormonal; Bone Density; Endometrium; Endosonography; Female; Gonadotropin-Releasing Hormone; Humans; Hysteroscopy; Leiomyoma; Lipid Metabolism; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms; Vasomotor System | 1999 |
A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
Topics: Administration, Cutaneous; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Norpregnenes; Progesterone Congeners; Treatment Outcome; Uterine Neoplasms | 2000 |
[The effects of menopausal replacement therapy in women with uterine myomas].
Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms | 1999 |
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
Topics: Adult; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Iron; Laparoscopy; Leiomyoma; Leuprolide; Norpregnenes; Placebos; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2001 |
Long term effects of Tibolone on postmenopausal women with uterine myomas.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Leiomyoma; Middle Aged; Norpregnenes; Postmenopause; Pulsatile Flow; Time; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus | 2001 |
Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy.
Topics: Adult; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leiomyoma; Middle Aged; Norpregnenes; Preoperative Care; Prospective Studies; Uterine Neoplasms | 2002 |
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density; Bone Development; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Postmenopause; Prospective Studies; Reference Values; Uterine Neoplasms | 2002 |
3 other study(ies) available for tibolone and Uterine Neoplasms
| Article | Year |
|---|---|
The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Uterine Neoplasms | 2009 |
Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125.
Topics: Antigens, Tumor-Associated, Carbohydrate; Diagnosis, Differential; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Neoplasms | 1994 |
Cause of vaginal bleeding in postmenopausal women taking tibolone.
Topics: Aged; Aged, 80 and over; Anabolic Agents; Carcinoma in Situ; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysteroscopy; Leiomyoma; Middle Aged; Norpregnenes; Polyps; Postmenopause; Time Factors; Ultrasonography, Doppler; Uterine Hemorrhage; Uterine Neoplasms | 1996 |